Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3070% above fair value
$29.53−1.32 (-4.28%)
Close on Nov 13, 2026Market cap $2.21BP/E –Yield –
Schrodinger price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Schrodinger's price to sales ratio was 9.0× on Nov 11, 2026, against 5.0× a year earlier. Over the last 5 years it ranged from 3.3× to 19.1×, with a median of 8.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.0× | +3.9 |
| 2025 | Dec 31, 2025 | 5.1× | −2.2 |
| 2024 | Dec 31, 2024 | 7.3× | −5.8 |
| 2023 | Dec 29, 2023 | 13.1× | +5.3 |
| 2022 | Dec 30, 2022 | 7.8× | −9.4 |
| 2021 | Dec 31, 2021 | 17.2× | −27.0 |
| 2020 | Dec 31, 2020 | 44.2× | – |
See a number that looks wrong?